254 related articles for article (PubMed ID: 19638505)
1. MEK4 function, genistein treatment, and invasion of human prostate cancer cells.
Xu L; Ding Y; Catalona WJ; Yang XJ; Anderson WF; Jovanovic B; Wellman K; Killmer J; Huang X; Scheidt KA; Montgomery RB; Bergan RC
J Natl Cancer Inst; 2009 Aug; 101(16):1141-55. PubMed ID: 19638505
[TBL] [Abstract][Full Text] [Related]
2. Genistein inhibits matrix metalloproteinase type 2 activation and prostate cancer cell invasion by blocking the transforming growth factor beta-mediated activation of mitogen-activated protein kinase-activated protein kinase 2-27-kDa heat shock protein pathway.
Xu L; Bergan RC
Mol Pharmacol; 2006 Sep; 70(3):869-77. PubMed ID: 16772519
[TBL] [Abstract][Full Text] [Related]
3. Genistein treatment duration effects biomarkers of cell motility in human prostate.
Zhang H; Gordon R; Li W; Yang X; Pattanayak A; Fowler G; Zhang L; Catalona WJ; Ding Y; Xu L; Huang X; Jovanovic B; Kelly DL; Jiang H; Bergan R
PLoS One; 2019; 14(3):e0214078. PubMed ID: 30917169
[TBL] [Abstract][Full Text] [Related]
4. MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer.
Xu L; Chen S; Bergan RC
Oncogene; 2006 May; 25(21):2987-98. PubMed ID: 16407830
[TBL] [Abstract][Full Text] [Related]
5. Genistein inhibits p38 map kinase activation, matrix metalloproteinase type 2, and cell invasion in human prostate epithelial cells.
Huang X; Chen S; Xu L; Liu Y; Deb DK; Platanias LC; Bergan RC
Cancer Res; 2005 Apr; 65(8):3470-8. PubMed ID: 15833883
[TBL] [Abstract][Full Text] [Related]
6. Sea cucumber extract TBL-12 inhibits the proliferation, migration, and invasion of human prostate cancer cells through the p38 mitogen-activated protein kinase and intrinsic caspase apoptosis pathway.
Yuan L; Huang X; Zhou K; Zhu X; Huang B; Qiu S; Cao K; Xu L
Prostate; 2019 Jun; 79(8):826-839. PubMed ID: 30889629
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1.
Ramer R; Hinz B
J Natl Cancer Inst; 2008 Jan; 100(1):59-69. PubMed ID: 18159069
[TBL] [Abstract][Full Text] [Related]
8. Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis.
Fu Z; Smith PC; Zhang L; Rubin MA; Dunn RL; Yao Z; Keller ET
J Natl Cancer Inst; 2003 Jun; 95(12):878-89. PubMed ID: 12813171
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of invasion and angiogenesis-related genes identified by cDNA microarray analysis of PC3 prostate cancer cells treated with genistein.
Li Y; Sarkar FH
Cancer Lett; 2002 Dec; 186(2):157-64. PubMed ID: 12213285
[TBL] [Abstract][Full Text] [Related]
10. Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein.
Li Y; Che M; Bhagat S; Ellis KL; Kucuk O; Doerge DR; Abrams J; Cher ML; Sarkar FH
Neoplasia; 2004; 6(4):354-63. PubMed ID: 15256057
[TBL] [Abstract][Full Text] [Related]
11. Crude extract of Euphorbia formosana inhibits the migration and invasion of DU145 human prostate cancer cells: The role of matrix metalloproteinase-2/9 inhibition via the MAPK signaling pathway.
Yang JL; Lin JH; Weng SW; Chen JC; Yang JS; Amagaya S; Funayana S; Wood WG; Kuo CL; Chung JG
Mol Med Rep; 2013 May; 7(5):1403-8. PubMed ID: 23525212
[TBL] [Abstract][Full Text] [Related]
12. Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer.
Li Y; Kucuk O; Hussain M; Abrams J; Cher ML; Sarkar FH
Cancer Res; 2006 May; 66(9):4816-25. PubMed ID: 16651437
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer.
Chen Y; Zaman MS; Deng G; Majid S; Saini S; Liu J; Tanaka Y; Dahiya R
Cancer Prev Res (Phila); 2011 Jan; 4(1):76-86. PubMed ID: 21071579
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow stromal cells enhance prostate cancer cell invasion through type I collagen in an MMP-12 dependent manner.
Nabha SM; dos Santos EB; Yamamoto HA; Belizi A; Dong Z; Meng H; Saliganan A; Sabbota A; Bonfil RD; Cher ML
Int J Cancer; 2008 Jun; 122(11):2482-90. PubMed ID: 18324629
[TBL] [Abstract][Full Text] [Related]
15. MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion.
Mehta PB; Jenkins BL; McCarthy L; Thilak L; Robson CN; Neal DE; Leung HY
Oncogene; 2003 Mar; 22(9):1381-9. PubMed ID: 12618764
[TBL] [Abstract][Full Text] [Related]
16. Genistein-selenium combination induces growth arrest in prostate cancer cells.
Kumi-Diaka J; Merchant K; Haces A; Hormann V; Johnson M
J Med Food; 2010 Aug; 13(4):842-50. PubMed ID: 20553187
[TBL] [Abstract][Full Text] [Related]
17. Rho-Associated Protein Kinase (ROCK) Promotes Proliferation and Migration of PC-3 and DU145 Prostate Cancer Cells by Targeting LIM Kinase 1 (LIMK1) and Matrix Metalloproteinase-2 (MMP-2).
Gong H; Zhou L; Khelfat L; Qiu G; Wang Y; Mao K; Chen W
Med Sci Monit; 2019 Apr; 25():3090-3099. PubMed ID: 31026254
[TBL] [Abstract][Full Text] [Related]
18. Genistein differentially modulates androgen-responsive gene expression and activates JNK in LNCaP cells.
Lazarevic B; Karlsen SJ; Saatcioglu F
Oncol Rep; 2008 May; 19(5):1231-5. PubMed ID: 18425381
[TBL] [Abstract][Full Text] [Related]
19. ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion.
Xiao LJ; Lin P; Lin F; Liu X; Qin W; Zou HF; Guo L; Liu W; Wang SJ; Yu XG
Int J Oncol; 2012 May; 40(5):1714-24. PubMed ID: 22200661
[TBL] [Abstract][Full Text] [Related]
20. Influence of genistein isoflavone on matrix metalloproteinase-2 expression in prostate cancer cells.
Kumi-Diaka JK; Hassanhi M; Merchant K; Horman V
J Med Food; 2006; 9(4):491-7. PubMed ID: 17201635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
